Related Experiment Video
Updated: Jan 21, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study
Song-Yun Chu1, Jie Jiang1, Yu-Ling Wang1
1Department of Cardiology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District,100034, Beijing, China.
Insights
Atrial fibrillation (AF) burden detected by pacemakers increases thromboembolism risk in patients with similar CHA₂DS₂-VASc scores. This finding suggests AF burden should be considered alongside existing stroke risk assessments.
Area of Science:
- Cardiology
- Medical Technology
Background:
- Atrial fibrillation (AF) burden is a potential risk factor for systemic embolism.
- Current stroke risk scores like CHA₂DS₂-VASc do not incorporate AF burden due to assessment difficulties.
- Dual-chamber pacemakers offer a method to quantify AF incidence and duration.
Purpose of the Study:
- To evaluate the association between AF burden and thromboembolism in patients with dual-chamber pacemakers.
- To determine if pacemaker-detected AF burden predicts thromboembolic events independently of CHA₂DS₂-VASc scores.
Main Methods:
- Retrospective cohort study of patients with dual-chamber pacemakers (October 2003 - May 2017).
- Exclusion of patients with prior thromboembolism or on anticoagulants.
- Propensity score matching and multivariate regression to analyze AF burden and thromboembolic outcomes.
Main Results:
- Patients with thromboembolism had higher CHA₂DS₂-VASc scores but not initially higher AF burden.
- In propensity score-matched cohorts, higher AF burden was linked to increased thromboembolism risk.
- Pacemaker-detected AF episodes >6 minutes significantly predicted future stroke or thromboembolism.
Conclusions:
- Pacemaker-detected AF burden is associated with an elevated risk of thromboembolism in patients with dual-chamber pacemakers, even with comparable CHA₂DS₂-VASc scores.
- Further research is needed to integrate AF burden into risk stratification models for guiding anticoagulation therapy.
Background:
Atrial fibrillation (AF) burden might link to increased risk of systemic embolism. Current scoring systems for evaluating stroke risks such as CHA2DS2-VASc do not incorporate AF burden partly because of the difficulty to assess these data. Patients with dual-chamber pacemakers implanted have opportunities to acquire incidence and duration of AF.
Objectives:
We aimed to evaluate the AF burden and its association with thromboembolism in patients with dual-chamber pacemakers.
Methods:
This retrospective cohort study enrolled patients who underwent dual-chamber pacemaker implantation at our center between October 2003 and May 2017. We excluded patients with prior thromboembolism or receiving anticoagulants. The incidence and duration of pacemaker-detected AF were compared between patients with and without thromboembolic outcomes. Propensity score matching (1:1) was conducted based on clinical characteristics. Multivariate regressions were performed to determine the predictors of thromboembolic outcomes. Survival free from stroke and thromboembolism was assessed using Kaplan-Meier analysis in groups with different AF burden.
Results:
Among the 152 patients enrolled (43.4% women; age 73.2 ± 13.3 years), ten experienced thromboembolic events within a median follow-up of 67 months. Patients with thromboembolisms had higher CHA2DS2-VASc scores but not higher AF burden. Higher CHA2DS2-VASc score was associated with increased risk for systemic thromboembolism [hazard ratio (HR), 1.87; 95% confidence interval (CI), 1.07-3.24; P = 0.027). In the propensity score-matched cohort with comparable CHA2DS2-VASc score, patients with thromboembolism had higher AF burden. Pacemaker-detected AF was associated with increased risk for thromboembolism (propensity-adjusted HR, 9.33; 95% CI, 1.19-72.99; P = 0.033). Experiencing AF episodes lasting >6 min was a predictor of significantly higher risk of future stroke or thromboembolism (propensity-adjusted HR, 6.75; 95% CI, 1.30-35.11; P = 0.023).
Conclusion:
In patients with dual-chamber pacemakers and comparable CHA2DS2-VASc score, pacemaker-detected AF burden is associated with elevated risk for thromboembolism. Further research is needed to clarify how pacemaker-detected AF burden could incorporate with CHA2DS2-VASc score variables and help to guide anticoagulation.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Relative Risk
Integration of Synaptic Events
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

